Objective Menopausal transition and early postmenopausal years have been described as a
“window of vulnerability” for the development of depressive symptoms or depression (new or …

Background Hot flashes can be troublesome, especially when hormonal therapy is
contraindicated. Preliminary data have suggested that newer antidepressants, such as …

Epidemiologic and clinic data have unequivocally supported the notion that women
experience more psychiatric problems at some point in their lives compared with men …

Importance Perimenopause is accompanied by an increased risk of new and recurrent
depression. The coincidence of declining ovarian function with the onset of depression led …

Women are at a higher risk than men to develop mood disorders and depression. The
increased risk is associated with fluctuating estrogen levels that occur during reproductive …

Objective: To compare the effectiveness and tolerability of gabapentin with placebo for the
treatment of hot flashes in women who enter menopause naturally. Design: A randomized …

Objective: To examine the efficacy and tolerability of escitalopram (ESCIT) compared to
estrogen and progestogen therapy (EPT) for the treatment of symptomatic peri-and …

Background The purpose of this study was to provide practical, evidence-based guidelines
for evaluating and treating common menopausal symptoms following breast cancer …

It has long been recognized that women are at a higher risk than men to develop depression
and that such risk is particularly associated with reproductive cycle events. Recent long …

Objective.—To report on the prevalence of comorbid migraine in bipolar disorder and the
implications for bipolar age of onset, psychiatric comorbidity, illness course, functional …